# A Study to Assess Safety and Immunogenicity of Conserved Mosaic HIV-1 Vaccines

> **NCT04586673** · PHASE1 · COMPLETED · sponsor: **University of Oxford** · enrollment: 13 (actual)

## Conditions studied

- HIV

## Interventions

- **BIOLOGICAL:** ChAdOx1.tHIVconsv1 (C1)
- **BIOLOGICAL:** ChAdOx1.tHIVconsv1 (C1)
- **BIOLOGICAL:** MVA.tHIVconsv3 (M3)
- **BIOLOGICAL:** MVA.tHIVconsv4 (M4)

## Key facts

- **NCT ID:** NCT04586673
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-03
- **Primary completion:** 2022-08-03
- **Final completion:** 2022-08-03
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2025-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04586673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04586673, "A Study to Assess Safety and Immunogenicity of Conserved Mosaic HIV-1 Vaccines". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT04586673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*